A citation-based method for searching scientific literature

Maarten L J Doornbos, Ilse Van der Linden, Liesbeth Vereyken, Gary Tresadern, Adriaan P IJzerman, Hilde Lavreysen, Laura H Heitman. Biochem Pharmacol 2018
Times Cited: 9







List of co-cited articles
38 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors.
Naichen Yu, Josephine M Atienza, Jerome Bernard, Sebastien Blanc, Jenny Zhu, Xiaobo Wang, Xiao Xu, Yama A Abassi. Anal Chem 2006
183
44


Whole-cell biosensor for label-free detection of GPCR-mediated drug responses in personal cell lines.
Julia M Hillger, Jeffison Schoop, Dorret I Boomsma, P Eline Slagboom, Adriaan P IJzerman, Laura H Heitman. Biosens Bioelectron 2015
27
33

Label-free whole-cell assays: expanding the scope of GPCR screening.
Clay W Scott, Matthew F Peters. Drug Discov Today 2010
102
33


Metabotropic glutamate receptors: from the workbench to the bedside.
F Nicoletti, J Bockaert, G L Collingridge, P J Conn, F Ferraguti, D D Schoepp, J T Wroblewski, J P Pin. Neuropharmacology 2011
423
22

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
P Jeffrey Conn, Arthur Christopoulos, Craig W Lindsley. Nat Rev Drug Discov 2009
777
22

The role of kinetic context in apparent biased agonism at GPCRs.
Carmen Klein Herenbrink, David A Sykes, Prashant Donthamsetti, Meritxell Canals, Thomas Coudrat, Jeremy Shonberg, Peter J Scammells, Ben Capuano, Patrick M Sexton, Steven J Charlton,[...]. Nat Commun 2016
209
22

Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
I Nederpelt, D Bleeker, B Tuijt, A P IJzerman, L H Heitman. Biochem Pharmacol 2016
13
22

From receptor binding kinetics to signal transduction; a missing link in predicting in vivo drug-action.
Indira Nederpelt, Maria Kuzikov, Wilbert E A de Witte, Patrick Schnider, Bruno Tuijt, Sheraz Gul, Adriaan P IJzerman, Elizabeth C M de Lange, Laura H Heitman. Sci Rep 2017
6
33

mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats.
Abdallah Ahnaou, Hilde Lavreysen, Gary Tresadern, Jose M Cid, Wilhelmus H Drinkenburg. PLoS One 2015
14
22

Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2.
Maarten L J Doornbos, José María Cid, Jordi Haubrich, Alexandro Nunes, Jasper W van de Sande, Sophie C Vermond, Thea Mulder-Krieger, Andrés A Trabanco, Abdellah Ahnaou, Wilhelmus H Drinkenburg,[...]. J Med Chem 2017
26
22

Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression.
Brice Campo, Mikhail Kalinichev, Nathalie Lambeng, M El Yacoubi, Isabelle Royer-Urios, Manfred Schneider, Coline Legrand, Delphine Parron, Francoise Girard, Abdelhak Bessif,[...]. J Neurogenet 2011
60
22

The application of cell-based label-free technology in drug discovery.
Biao Xi, Naichen Yu, Xiaobo Wang, Xiao Xu, Yama A Abassi. Biotechnol J 2008
117
22


Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222.
Maarten L J Doornbos, Laura Pérez-Benito, Gary Tresadern, Thea Mulder-Krieger, Ilse Biesmans, Andrés A Trabanco, Jose María Cid, Hilde Lavreysen, Adriaan P IJzerman, Laura H Heitman. Br J Pharmacol 2016
30
22

CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
S Litschig, F Gasparini, D Rueegg, N Stoehr, P J Flor, I Vranesic, L Prézeau, J P Pin, C Thomsen, R Kuhn. Mol Pharmacol 1999
281
22

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.
A E Kingston, P L Ornstein, R A Wright, B G Johnson, N G Mayne, J P Burnett, R Belagaje, S Wu, D D Schoepp. Neuropharmacology 1998
312
22


The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia.
P J Harrison, L Lyon, L J Sartorius, P W J Burnet, T A Lane. J Psychopharmacol 2008
122
22

Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors.
John O DiRaddo, Eric J Miller, Carrie Bowman-Dalley, Barbara Wroblewska, Monica Javidnia, Ewa Grajkowska, Barry B Wolfe, Dennis C Liotta, Jarda T Wroblewski. Mol Pharmacol 2015
7
28

Metabotropic glutamate receptors as drug targets: what's new?
Ferdinando Nicoletti, Valeria Bruno, Richard Teke Ngomba, Roberto Gradini, Giuseppe Battaglia. Curr Opin Pharmacol 2015
70
22


Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line.
Amy N Y Chen, Daniel T Malone, Kavita Pabreja, Patrick M Sexton, Arthur Christopoulos, Meritxell Canals. J Biomol Screen 2015
5
40

Label-free cell-based assays for GPCR screening.
Ye Fang, Anthony G Frutos, Ronald Verklereen. Comb Chem High Throughput Screen 2008
67
22

The structure and function of G-protein-coupled receptors.
Daniel M Rosenbaum, Søren G F Rasmussen, Brian K Kobilka. Nature 2009
22

Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
Craig W Lindsley, Kyle A Emmitte, Corey R Hopkins, Thomas M Bridges, Karen J Gregory, Colleen M Niswender, P Jeffrey Conn. Chem Rev 2016
115
22

GPCR desensitization: Acute and prolonged phases.
Sudarshan Rajagopal, Sudha K Shenoy. Cell Signal 2018
153
22

Using label-free screening technology to improve efficiency in drug discovery.
Reena Halai, Matthew A Cooper. Expert Opin Drug Discov 2012
27
22

TGFα shedding assay: an accurate and versatile method for detecting GPCR activation.
Asuka Inoue, Jun Ishiguro, Hajime Kitamura, Naoaki Arima, Michiyo Okutani, Akira Shuto, Shigeki Higashiyama, Tomohiko Ohwada, Hiroyuki Arai, Kumiko Makide,[...]. Nat Methods 2012
204
22

Trends in GPCR drug discovery: new agents, targets and indications.
Alexander S Hauser, Misty M Attwood, Mathias Rask-Andersen, Helgi B Schiöth, David E Gloriam. Nat Rev Drug Discov 2017
22

Functional assays for screening GPCR targets.
William Thomsen, John Frazer, David Unett. Curr Opin Biotechnol 2005
154
22

G proteins.
J R Hepler, A G Gilman. Trends Biochem Sci 1992
913
22

Label-free impedance-based whole cell assay to study GPCR pharmacology.
Maarten L J Doornbos, Laura H Heitman. Methods Cell Biol 2019
3
66

Tools for GPCR drug discovery.
Ru Zhang, Xin Xie. Acta Pharmacol Sin 2012
186
22

Luciferase Reporter Assay System for Deciphering GPCR Pathways.
Zhijie Cheng, Denise Garvin, Aileen Paguio, Pete Stecha, Keith Wood, Frank Fan. Curr Chem Genomics 2010
104
22

Illuminating G-Protein-Coupling Selectivity of GPCRs.
Asuka Inoue, Francesco Raimondi, Francois Marie Ngako Kadji, Gurdeep Singh, Takayuki Kishi, Akiharu Uwamizu, Yuki Ono, Yuji Shinjo, Satoru Ishida, Nadia Arang,[...]. Cell 2019
171
22


Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies.
Hiba Salih, Ion Anghelescu, Iva Kezic, Vikash Sinha, Eef Hoeben, Luc Van Nueten, Heidi De Smedt, Peter De Boer. J Psychopharmacol 2015
35
11

The Role of Binding Kinetics in GPCR Drug Discovery.
David C Swinney, Brad A Haubrich, Isabelle Van Liefde, Georges Vauquelin. Curr Top Med Chem 2015
34
11

Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor.
Dong Guo, Suzanne N Venhorst, Arnault Massink, Jacobus P D van Veldhoven, Georges Vauquelin, Adriaan P IJzerman, Laura H Heitman. Br J Pharmacol 2014
16
11

The drug-target residence time model: a 10-year retrospective.
Robert A Copeland. Nat Rev Drug Discov 2016
348
11

1,3,5-Trisubstituted Pyrazoles as Potent Negative Allosteric Modulators of the mGlu2/3 Receptors.
Michiel Van Gool, Sergio A Alonso De Diego, Oscar Delgado, Andrés A Trabanco, Fabrice Jourdan, Gregor J Macdonald, Marijke Somers, Luc Ver Donck. ChemMedChem 2017
5
20


Ionotropic and metabotropic glutamate receptor structure and pharmacology.
James N C Kew, John A Kemp. Psychopharmacology (Berl) 2005
478
11

Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression.
Justine M Kent, Ella Daly, Iva Kezic, Rosanne Lane, Pilar Lim, Heidi De Smedt, Peter De Boer, Luc Van Nueten, Wayne C Drevets, Marc Ceusters. Prog Neuropsychopharmacol Biol Psychiatry 2016
34
11

The metabotropic glutamate receptors: structure and functions.
J P Pin, R Duvoisin. Neuropharmacology 1995
11

G protein-coupled receptor allosterism and complexing.
Arthur Christopoulos, Terry Kenakin. Pharmacol Rev 2002
698
11

Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia.
Sophie J Bradley, Christopher J Langmead, Jeannette M Watson, R A John Challiss. Mol Pharmacol 2011
36
11

[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
R A Wright, M B Arnold, W J Wheeler, P L Ornstein, D D Schoepp. J Pharmacol Exp Ther 2001
76
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.